Physician profile
Lori Arnold
NPI 1740341957
$565.90
in general payments reported to CMS, 2019-2025
6 companies · $22.52 in 2025
The $22.52 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $78.50 · 2021: $63.39 · 2022: $128 · 2023: $38.74 · 2024: $94.67 · 2025: $22.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112 · Debt Forgiveness: $43.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.32 |
| Debt Forgiveness | $43.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $146.73 | 2022-2025 | Pregnyl, Follistim Aq, Ganirelix Acetate |
| Merck Sharp & Dohme LLC | $139.08 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $127.26 | 2019-2021 | |
| Glaxosmithkline, LLC. | $93.47 | 2022-2024 | Trelegy Ellipta |
| Vitrolife INC. | $43.61 | 2024 | |
| Emd Serono, INC. | $15.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.